Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients

BACKGROUND: Hospitalized acutely ill medical patients are at risk for fatal and major thromboembolic events. Whether use of extended-duration primary thromboprophylaxis can prevent such events is unknown. OBJECTIVES: The purpose of this study was to evaluate whether extended-duration rivaroxaban red...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Am Coll Cardiol
Autores principales: Spyropoulos, Alex C., Ageno, Walter, Albers, Gregory W., Elliott, C. Gregory, Halperin, Jonathan L., Hiatt, William R., Maynard, Gregory A., Steg, P. Gabriel, Weitz, Jeffrey I., Lu, Wentao, Spiro, Theodore E., Barnathan, Elliot S., Raskob, Gary. E.
Formato: Artigo
Lenguaje:Inglês
Publicado: The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7308003/
https://ncbi.nlm.nih.gov/pubmed/32586587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2020.04.071
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares